14158 Results (Page 432 of 567)
All Market Research Reports
Italy Clinical Diagnostics Market Analysis
Italy's clinical diagnostic market was valued at $1.65 Bn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022-30 and will reach $2.53 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in technology and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux, Sysmex, Giesse Diagnostics Srl, Diagnostic Center NSL Italy, Sentinel Diagnostics, DiaSorin, Menarini Diagnostics, Epitech Group and others.
Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
The Belgium Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.02 Bn in 2022 to $0.3 Bn by 2030, registering a CAGR of 45.22% during the forecast period of 2022 - 2030. The market will be driven by a strong healthcare system, a culture of innovation, and government support for research and development. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, OncoDNA & FibriCheck.
US 3D Printing Medical Devices Market Analysis
The US 3D printing medical devices market is projected to grow from $1.2 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 14.3% during the forecast period of 2022-30. 3D printing enables medical devices to be customized to the individual patient's needs, which can improve patient outcomes and satisfaction. The US 3D printing medical devices market is highly competitive, with several established players and new entrants vying for market share. Some of the major players in the US 3D printing medical devices market include Stratasys, Stryker Corporation, 3D Systems, and Materialise NV
Thailand Cardiovascular Diseases Therapeutics Market Analysis
The Thailand cardiovascular disease therapeutics market is projected to grow from $195 Mn in 2022 to $350 Mn in 2030 with a CAGR of 7.56% for the year 2022-2030. The increasing elderly population and the rising demand for novel therapeutic options for cardiovascular diseases are the major market drivers for the growth of the market. The Thailand cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Silom Medical, Onimax, and Sun Pharmaceutical are the major players in the Thailand cardiovascular disease therapeutics market.
South Korea Cardiovascular Diseases Therapeutics Market Analysis
The South Korean cardiovascular disease therapeutics market is projected to grow from $2.37 Bn in 2022 to $4.47 Bn in 2030 with a CAGR of 8.22% for the year 2022-2030. The increasing awareness of cardiovascular diseases and the rising ageing population are responsible for the growth of the market. The South Korean cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Kolmar, Kwang Dong Pharmaceutical, and AstraZeneca are the major players in the South Korean cardiovascular disease therapeutics market.
South Africa Cardiovascular Diseases Therapeutics Market Analysis
The South African cardiovascular disease therapeutics market is projected to grow from $1.05 Bn in 2022 to $2.02 Bn in 2030 with a CAGR of 8.45% for the year 2022-2030. The rising elderly population leading to the increasing incidence of cardiovascular diseases in South Africa is responsible for the growth of the market. The South African cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Wraps, Afriplex, and Daiichi Sankyo are the major players in the South African cardiovascular disease therapeutics market.
UAE 3D Printing Medical Devices Market Analysis
UAE 3D printing medical device Market is expected to witness growth from $15 Mn in 2022 to $53 Mn in 2030 with a CAGR of 17.30% for the forecasted year 2022-30. Increasing demand for customized medical devices in the United Arab Emirates, technological advancements, rising healthcare spending, and rising awareness of 3D printing technology are some of the major market growth factors for makers in this sector. The market is segmented by product segmented by application, technology, and end user. Some key players in this market include Bin Ali Medical Supplies, Immensa Technology Labs, Proto21, GE Healthcare, Stryker, and Medtronic.
Saudi Arabia Cardiovascular Diseases Therapeutics Market Analysis
The Saudi Arabia cardiovascular disease therapeutics market is projected to grow from $2.76 Bn in 2022 to $5.39 Bn in 2030 with a CAGR of 8.72% for the year 2022-2030. Increased healthcare spending and government initiatives like Vision 2030 in Saudi Arabia are the major market drivers for the growth of the market. The Saudi Arabia cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Saudi Centre Group, Riyadh Pharma, and Gilead Sciences are the major players in the Saudi Arabia cardiovascular disease therapeutics market.
Italy 3D Printing Medical Devices Market Analysis
Italy's 3D printing medical devices market size was valued at $71 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.8% from 2022 to 2030 and will reach $230 Mn in 2030. The market is segmented by component, application, technology, and end user. The Italy 3D Printing Medical Devices market will grow 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include 3D-Side, EGO3D, Mecuris Italia, MT Ortho, REJOINT, Storm Line, WASP MED, and others.
Germany 3D Printing Medical Devices Market Analysis
Germany's 3D printing medical devices market size was valued at $109 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030 and will reach $321 Mn in 2030. The market is segmented by component, application, technology, and end user. The Germany 3D printing medical devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include SLM Solutions Group AG, EOS GmbH, Concept Laser GmbH, Materialise NV, Stratasys Ltd, 3D Systems Corporation, and others.
Philippines Cardiovascular Diseases Therapeutics Market Analysis
The Philippines cardiovascular disease therapeutics market is expected to witness growth from $358 Mn in 2022 to $649 Mn in 2030 with a CAGR of 7.72% for the forecasted year 2022-2030. due to the rising prevalence of cardiovascular diseases in the Philippines. Furthermore, the increase in healthcare spending in the Philippines has resulted in the expansion of the market. The Philippines cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Prosel Pharmaceuticals, Morishita-Segg'S Pharmaceuticals, and Fresenius Kabi are the major players in the Philippines cardiovascular disease therapeutics market.
France 3D Printing Medical Devices Market Analysis
France's 3D printing medical devices market size was valued at $82 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.3% from 2022 to 2030 and reach $255 Mn in 2030. The market is segmented by component, application, technology, and end user. The 3D-printed medical devices market in France will grow as the development of new 3D printing materials and techniques leads to the production of more complex and customizable medical devices. The key market players are AnatomikModeling, EOS, Impression 3D Médicale, InSimo, OsseoMatrix, Poietis, and SpineVisionare, among others.
Netherlands Cardiovascular Diseases Therapeutics Market Analysis
The Netherlands cardiovascular disease therapeutics market is expected to witness growth from $423 Mn in 2022 to $767 Mn in 2030 with a CAGR of 7.72% for the year 2022-2030. The Netherlands being the hub for rising trends in biochemistry, genetics, and molecular biology and the increase in demand for advanced therapeutics for the treatment of cardiovascular diseases in the Netherlands are the major factors responsible for the expansion of the market. The Netherlands cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Northsea Therapeutics, Dannalab, and AstraZeneca are the major players in the Netherlands cardiovascular disease therapeutics market.
Malaysia Cardiovascular Diseases Therapeutics Market Analysis
The Malaysia cardiovascular disease therapeutics market is projected to grow from $261 Mn in 2022 to $464 Mn in 2030 with a CAGR of 7.42% for the year 2022-2030. The rising elderly population and increased prevalence of cardiovascular diseases in Malaysia are the major factors responsible for the growth of the market. The Malaysia cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Xepa-Soul Pattinson, Hyphens Pharma, and Novartis are the major players in the Malaysia cardiovascular disease therapeutics market.
Egypt Cardiovascular Diseases Therapeutics Market Analysis
The Egypt cardiovascular disease therapeutics market is expected to witness growth from $455 Mn in 2022 to $889 Mn in 2030 with a CAGR of 8.72% for the year 2022-2030. The increasing elderly population in Egypt and the government initiatives like Back to Rhyth and the Nile Heart Challenge to increase awareness about cardiovascular disease in Egypt are the major growth drivers of the market. The Egypt cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Copad Pharma, Menarini Pharmaceutical, and Novartis are the major players in the Egypt cardiovascular disease therapeutics market.
UK Depression Therapeutics Market Analysis
The UK depression therapeutics market is expected to witness growth from $263 Mn in 2022 to $338 Mn in 2030 with a CAGR of 3.2% for the forecast year 2022-2030. The rising cases of depression in the UK particularly in the younger generation and their subsequent demand for novel therapeutic options are responsible for the growth of the market. The UK depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Curium Pharma, Chatfield Pharmaceuticals, and Abbott Laboratories are the major players in the UK depression therapeutics market.
Australia 3D Printing Medical Devices Market Analysis
Australia's 3D printing medical devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. The market is segmented by component, application, technology, and end user. The Australia 3D Printing Medical Devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include Anatomics, Osteopore, MELD Manufacturing Corporation, 3D Medical Limited, Stratasys, Materialise, Stryker, and others.
Spain Depression Therapeutics Market Analysis
The Spain depression therapeutics market is expected to witness growth from $195 Mn in 2022 to $271 Mn in 2030 with a CAGR of 4.2% for the forecasted year 2022-2030. The increasing incidence of depression in Spain and rising healthcare expenditure are the major growth drivers of the market. The Spain depression therapeutics market is segmented by drug type, therapies, indication, and by end users. TecnyFarma, Pharmaloop, and Pfizer are the major players in the Spain depression therapeutics market.
Philippines Depression Therapeutics Market Analysis
The Philippines' depression therapeutics market is expected to witness growth from $22 Mn in 2022 to $35 Mn in 2030 with a CAGR of 5.7% for the forecasted year 2022-2030. The rising investments in developing depression medications in the Philippines and the growing economy of the Philippines are responsible for the expansion of the market. The Philippines depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Maridan, MedChoice Pharma, and AstraZeneca are the major players in the Philippines' depression therapeutics market.
Japan Depression Therapeutics Market Analysis
The Japan depression therapeutics market is expected to witness growth from $628 Mn in 2022 to $978 Mn in 2030 with a CAGR of 5.7% for the forecasted year 2022-2030. The growth in research and development initiatives in Japan and the increasing prevalence of depression among the Japanese population are driving the growth of the market. The Japan depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, and AstraZeneca are the major players in the Japan depression therapeutics market.
Italy Depression Therapeutics Market Analysis
The Italy depression therapeutics market is expected to witness growth from $242 Mn in 2022 to $350 Mn in 2030 with a CAGR of 4.7% for the forecasted year 2022-2030. The rising incidence of depression in Italy and the growing demand for novel therapeutics are responsible for the growth of the market. The Italy depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Procos, Indena, and Cipla are the major players in the Italy depression therapeutics market.
India Depression Therapeutics Market Analysis
The India depression therapeutics market is expected to witness growth from $184 Mn in 2022 to $345 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-2030. The increasing investments in research and development projects for depression in India along with supportive government policies are responsible for the growth of the market. The Indian depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Mediwin Pharmaceuticals, Zydus Cadila, and GlaxoSmithKline are the major players in the Indian depression therapeutics market.
Germany Depression Therapeutics Market Analysis
The German depression therapeutics market is expected to witness growth from $370 Mn in 2022 to $483 Mn in 2030 with a CAGR of 3.4% for the forecasted year 2022-2030. The growing awareness of depression and the rising technological advancements like telemedicine and digital therapeutics are the major market drivers. The German depression therapeutics market is segmented by drug type, therapies, indication, and by end users. ix Therapeutics, Denk Pharma, and AstraZeneca are the major players in the German depression therapeutics market.
France Depression Therapeutics Market Analysis
The France depression therapeutics market is expected to witness growth from $278 Mn in 2022 to $386 Mn in 2030 with a CAGR of 4.2% for the forecasted year 2022-2030. The rising incidence of depression and the development of several innovative treatments for depression in France are the major market drivers. The France depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Pharmaleads, Elaiapharm, and AbbVie are the major players in the France depression therapeutics market.
Egypt Depression Therapeutics Market Analysis
The Egypt depression therapeutics market is expected to witness growth from $28 Mn in 2022 to $48 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-2030. The growing incidence of depression in Egypt and its improving health infrastructure has resulted in the growth of the market. The Egypt depression therapeutics market is segmented by drug type, therapies, indication, and by end users. FPi Future Pharmaceutical, Quadri Pharma, and GlaxoSmithKline are the major players in the Egypt depression therapeutics market.
